Satlin Andrew 4
4 · Intra-Cellular Therapies, Inc. · Filed Nov 15, 2017
Insider Transaction Report
Form 4
Satlin Andrew
EVP and Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2017-11-13+170,500→ 170,500 totalExercise: $14.79Exp: 2027-11-12→ Common Stock (170,500 underlying)
Footnotes (1)
- [F1]The option vests as to one third of the shares on November 13, 2018, one third of the shares on November 13, 2019 and one third of the shares on November 13, 2020.